Published in Breast Cancer Res on April 24, 2008
A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell (2010) 1.72
miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res (2010) 1.54
Whole-Exome Sequencing in Familial Parkinson Disease. JAMA Neurol (2016) 1.45
Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing. Cancer Res (2010) 1.41
GIV/Girdin is a rheostat that fine-tunes growth factor signals during tumor progression. Cell Adh Migr (2011) 1.31
Shepherding AKT and androgen receptor by Ack1 tyrosine kinase. J Cell Physiol (2010) 1.13
Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy. Ann Neurol (2013) 1.07
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors. Oncotarget (2011) 1.01
Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling. J Biol Chem (2009) 0.94
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma. Mol Cancer (2010) 0.94
SVM classifier to predict genes important for self-renewal and pluripotency of mouse embryonic stem cells. BMC Syst Biol (2010) 0.90
SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation. Oncogene (2012) 0.89
Targeting Cdc42 in cancer. Expert Opin Ther Targets (2013) 0.85
Cortactin is a substrate of activated Cdc42-associated kinase 1 (ACK1) during ligand-induced epidermal growth factor receptor downregulation. PLoS One (2012) 0.84
Drosophila activated Cdc42 kinase has an anti-apoptotic function. PLoS Genet (2012) 0.81
Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection. BMC Genomics (2014) 0.79
Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death. J Biol Chem (2013) 0.78
Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women. Epigenetics (2015) 0.78
Targeted extracellular nanoparticles enable intracellular detection of activated epidermal growth factor receptor in living brain cancer cells. Nanomedicine (2011) 0.78
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol (2005) 16.77
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol (2006) 6.86
Epidermal growth factor receptor (EGFR) signaling in cancer. Gene (2005) 6.04
Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol (2003) 5.22
Rho GTPases: signaling, migration, and invasion. Exp Cell Res (2000) 2.82
A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature (1993) 2.60
Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res (2005) 1.97
The EGF receptor is an actin-binding protein. J Cell Biol (1992) 1.86
Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci U S A (2005) 1.82
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol (1987) 1.72
Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell (2003) 1.61
Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation. Int J Surg Pathol (2005) 1.55
Cloning and characterization of a novel Cdc42-associated tyrosine kinase, ACK-2, from bovine brain. J Biol Chem (1997) 1.54
Epidermal growth factor receptors associated to cytoskeletal elements of epidermoid carcinoma (A431) cells. J Cell Biol (1986) 1.43
Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation. Mol Biol Cell (2006) 1.37
Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli. Proc Natl Acad Sci U S A (2006) 1.37
The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J Biol Chem (2001) 1.35
The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol (1998) 1.32
The Cdc42 target ACK2 interacts with sorting nexin 9 (SH3PX1) to regulate epidermal growth factor receptor degradation. J Biol Chem (2002) 1.23
PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res (1997) 1.23
Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas. J Biol Chem (2006) 1.13
Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. Cancer Res (2006) 1.09
Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells. Mol Vis (2003) 1.07
Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation. Biochem Biophys Res Commun (2000) 1.06
Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat (2004) 1.06
Resistance to epidermal growth factor receptor-targeted therapy. Drug Resist Updat (2005) 1.03
The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation. Oncogene (1999) 0.97
Modulation of epidermal growth factor receptor interaction with the detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity. Endocrinology (1995) 0.91
New agents in development for breast cancer. Curr Opin Obstet Gynecol (2007) 0.79
Construction of a cell-permeable CDC42 binding fragment of ACK that inhibits v-Ha-Ras transformation. Ann N Y Acad Sci (1999) 0.78
Gamma knife surgery for dural arteriovenous shunts: 25 years of experience. J Neurosurg (2006) 2.14
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res (2002) 1.93
Natural history of dural arteriovenous shunts. Stroke (2008) 1.91
Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res (2005) 1.77
Image noise reduction algorithm for digital subtraction angiography: clinical results. Radiology (2013) 1.64
Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells. Mol Cell Biol (2006) 1.45
Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res (2006) 1.43
p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med (2004) 1.42
Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke (2012) 1.41
Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clin Cancer Res (2005) 1.41
A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem (2005) 1.32
The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin Cancer Res (2008) 1.28
A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A (2009) 1.25
Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem (2009) 1.18
Management of patients with brain arteriovenous malformations. Eur J Radiol (2003) 1.15
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab (2009) 1.14
p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp Cell Res (2004) 1.13
Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J Biol Chem (2004) 1.13
p38 Mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J (2001) 1.10
Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner. J Biol Chem (2009) 1.07
WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer (2014) 1.05
Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant (2011) 1.04
Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. Int J Cancer (2003) 1.03
Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. Histol Histopathol (2010) 1.02
Management strategies for anterior cranial fossa (ethmoidal) dural arteriovenous fistulas with an emphasis on endovascular treatment. J Neurosurg (2009) 1.02
PhRMA white paper on ADME pharmacogenomics. J Clin Pharmacol (2008) 0.99
Radiation dose in neuroangiography using image noise reduction technology: a population study based on 614 patients. Neuroradiology (2013) 0.99
Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome. PLoS One (2011) 0.99
Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin Pharmacokinet (2004) 0.98
WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity. PLoS One (2011) 0.96
Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. PLoS One (2011) 0.95
Nitric oxide produced in response to engagement of beta2 integrins on human neutrophils activates the monomeric GTPases Rap1 and Rap2 and promotes adhesion. J Biol Chem (2006) 0.94
Retracted Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells. Proc Natl Acad Sci U S A (2009) 0.94
Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Exp Cell Res (2006) 0.93
Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients. Int J Cancer (2010) 0.92
Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum. Eur J Immunol (2005) 0.92
Omeprazole disposition in children following single-dose administration. J Clin Pharmacol (2003) 0.90
Endovascular transplantation of stem cells to the injured rat CNS. Neuroradiology (2009) 0.89
Neuronavigation for arteriovenous malformation surgery by intraoperative three-dimensional ultrasound angiography. Neurosurgery (2007) 0.88
Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling. J Immunol (2004) 0.87
Oxidized low-density lipoprotein induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 endothelial cells. Biochem J (2003) 0.87
Down-regulation of Rac activity during beta 2 integrin-mediated adhesion of human neutrophils. J Biol Chem (2003) 0.87
Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole. Br J Clin Pharmacol (2007) 0.85
Psychosocial characteristics at age 10; differentiating between adult alcohol use pathways: a prospective longitudinal study. Addict Behav (2002) 0.85
Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and retinoic acid. Thyroid (2005) 0.84
Contribution of the fibrinolytic pathway to hematopoietic regeneration. J Cell Physiol (2009) 0.84
Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils. Biochem J (2003) 0.83
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells. Mol Oncol (2013) 0.83
Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study. Clin Ther (2006) 0.82
WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis (2013) 0.81
Engagement of beta2 integrins recruits 14-3-3 proteins to c-Cbl in human neutrophils. Biochem Biophys Res Commun (2004) 0.81
Retracted The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer. Cell Cycle (2009) 0.81
Patients with subarachnoid haemorrhage from vertebrobasilar dissection: treatment with stent-in-stent technique. Neuroradiology (2015) 0.81
Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study. Clin Ther (2006) 0.80
Mechanical thrombectomy in acute ischemic stroke-experience from 6 years of practice. Neuroradiology (2014) 0.79
E3B1, a human homologue of the mouse gene product Abi-1, sensitizes activation of Rap1 in response to epidermal growth factor. Exp Cell Res (2005) 0.79
Advances in interventional neuroradiology 2005. Stroke (2006) 0.79
The prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women. PLoS One (2013) 0.78
A Wnt5a signaling pathway in the pathogenesis of HIV-1 gp120-induced pain. Pain (2015) 0.78
Dietary supplementation with carbonate increases expression of ornithine decarboxylase and proliferation in gastric mucosa in a rat model of gastric cancer. Int J Cancer (2008) 0.77
The adhesion receptor CD-31 can be primed to rapidly adjust the neutrophil cytoskeleton. Biochem Biophys Res Commun (2002) 0.77
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer. Cancer Med (2012) 0.76
Endovascular treatment for acute ischemic stroke. N Engl J Med (2013) 0.75
What do white matter hyperintensities really represent? Stroke (2010) 0.75
Dietary supplementation of carbonate promotes spontaneous tumorigenesis in a rat gastric stump model. Scand J Gastroenterol (2006) 0.75
[Spinal dural arteriovenous fistula--uncommon, curable cause of paraplegia. Early diagnosis and treatment can result in total symptom regression]. Lakartidningen (2010) 0.75
[Three studies on thrombectomy in acute stroke. Very limited relevance to today's practice]. Lakartidningen (2013) 0.75
Image Noise Reduction Algorithm for Digital Subtraction Angiography: Clinical Results. Radiology (2016) 0.75
Beta2 integrins target Rap GTPases to the plasma membrane by means of degranulation. Biochem Biophys Res Commun (2008) 0.75
Stroke review: advances in interventional neuroradiology 2004. Stroke (2004) 0.75